Related Experiment Video
Updated: Feb 6, 2026

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
Probiotics for management of infantile colic: a systematic review of randomized controlled trials
Radoslaw Dryl1, Hanna Szajewska1
1Department of Paediatrics, Medical University of Warsaw, Warsaw, Poland.
Insights
Probiotics, particularly Lactobacillus reuteri DSM 17938, may help manage infantile colic by reducing crying times, especially in breastfed infants. Further research is needed for other probiotic strains.
Area of Science:
- Pediatric Gastroenterology
- Microbiome Research
Background:
- Infantile colic is a prevalent pediatric condition with unknown etiology and limited treatment options.
- Probiotics are being investigated for their potential benefits in managing infantile colic.
Purpose of the Study:
- To systematically evaluate the effectiveness of probiotic supplementation in infantile colic management.
- To assess treatment success and crying duration as outcome measures.
Main Methods:
- A systematic review of randomized controlled trials (RCTs) was conducted.
- Searched MEDLINE and Cochrane Library up to April 2016 for relevant studies.
- Included RCTs comparing probiotics to placebo for infantile colic.
Main Results:
- Seven RCTs involving 471 participants were analyzed.
- Lactobacillus reuteri DSM 17938 significantly improved treatment success and reduced crying duration in exclusively breastfed infants.
- Other probiotic strains showed limited evidence due to single-trial studies.
Conclusions:
- Lactobacillus reuteri DSM 17938 is a potential probiotic option for infantile colic management.
- Evidence for other probiotics in infantile colic is currently limited.
Introduction:
Infantile colic is a common pediatric problem. The cause of infantile colic remains unclear. Treatment options are limited. Evidence suggests that probiotics might offer some benefit. The aim of the study was to systematically assess the effectiveness of probiotics supplementation in the management of infantile colic.
Material And Methods:
MEDLINE and the Cochrane Library were searched up to April 2016 for randomized controlled trials (RCTs) evaluating the efficacy of probiotics (any well-defined strain) compared with placebo for the management of infantile colic. The outcome measures of interest were treatment success and the duration of crying at the end of the intervention.
Results:
Seven RCTs (471 participants) were included. Compared with placebo the administration of Lactobacillus reuteri DSM 17938 at a daily dose of 108 CFU was associated with the treatment success (relative risk = 1.67, 95% CI: 1.10-2.81, number needed to treat 5, 95% CI: 4-8) and reduced crying times at the end of the intervention (mean difference: -49 min, 95% CI: -66 to -33); however, the effect was mainly seen in exclusively breastfed infants. Other probiotics (single or in combinations) were studied in single trials only.
Conclusions:
Some probiotics, primarily L. reuteri DSM 17938, may be considered for the management of infantile colic. Data on other probiotics are limited.
More Related Videos
Related Concept Videos
Random and Systematic Errors
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Clinical Trials: Overview
Trial and Error and Algorithm
Clinical Trials
There are four phases in a clinical trial. A phase one...

